• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管病理生理学中的细胞外囊泡:通讯、生物标志物及治疗潜力

Extracellular Vesicles in Cardiovascular Pathophysiology: Communications, Biomarkers, and Therapeutic Potential.

作者信息

Cui Zhe, Zhang Ling, Hu Guangyu, Zhang Fuyang

机构信息

Department of Cardiology, Xijing Hospital, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.

出版信息

Cardiovasc Toxicol. 2024 Aug;24(8):711-726. doi: 10.1007/s12012-024-09875-0. Epub 2024 Jun 7.

DOI:10.1007/s12012-024-09875-0
PMID:38844744
Abstract

Extracellular vesicles (EVs) are diverse, membrane-bound vesicles released from cells into the extracellular environment. They originate from either endosomes or the cell membrane and typically include exosomes and microvesicles. These EVs serve as crucial mediators of intercellular communication, carrying a variety of contents such as nucleic acids, proteins, and lipids, which regulate the physiological and pathological processes of target cells. Moreover, the molecular cargo of EVs can reflect critical information about the originating cells, making them potential biomarkers for the diagnosis and prognosis of diseases. Over the past decade, the role of EVs as key communicators between cell types in cardiovascular physiology and pathology has gained increasing recognition. EVs from different cellular sources, or from the same source under different cellular conditions, can have distinct impacts on the management, diagnosis, and prognosis of cardiovascular diseases. Furthermore, it is essential to consider the influence of cardiovascular-derived EVs on the metabolism of peripheral organs. This review aims to summarize recent advancements in the field of cardiovascular research with respect to the roles and implications of EVs. Our goal is to provide new insights and directions for the early prevention and treatment of cardiovascular diseases, with an emphasis on the therapeutic potential and diagnostic value of EVs.

摘要

细胞外囊泡(EVs)是从细胞释放到细胞外环境中的多种膜结合囊泡。它们起源于内体或细胞膜,通常包括外泌体和微囊泡。这些细胞外囊泡作为细胞间通讯的关键介质,携带多种内容物,如核酸、蛋白质和脂质,调节靶细胞的生理和病理过程。此外,细胞外囊泡的分子货物可以反映有关起源细胞的关键信息,使其成为疾病诊断和预后的潜在生物标志物。在过去十年中,细胞外囊泡作为心血管生理学和病理学中细胞类型之间关键通讯者的作用越来越受到认可。来自不同细胞来源或同一来源在不同细胞条件下的细胞外囊泡,对心血管疾病的管理、诊断和预后可能有不同影响。此外,必须考虑心血管来源的细胞外囊泡对外周器官代谢的影响。本综述旨在总结心血管研究领域中关于细胞外囊泡作用和影响的最新进展。我们的目标是为心血管疾病的早期预防和治疗提供新的见解和方向,重点是细胞外囊泡的治疗潜力和诊断价值。

相似文献

1
Extracellular Vesicles in Cardiovascular Pathophysiology: Communications, Biomarkers, and Therapeutic Potential.心血管病理生理学中的细胞外囊泡:通讯、生物标志物及治疗潜力
Cardiovasc Toxicol. 2024 Aug;24(8):711-726. doi: 10.1007/s12012-024-09875-0. Epub 2024 Jun 7.
2
Extracellular vesicle interplay in cardiovascular pathophysiology.细胞外囊泡在心血管病理生理学中的相互作用。
Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1749-H1761. doi: 10.1152/ajpheart.00925.2020. Epub 2021 Mar 5.
3
Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications.细胞外囊泡与心血管疾病:生物学功能与治疗意义。
Pharmacol Ther. 2022 May;233:108025. doi: 10.1016/j.pharmthera.2021.108025. Epub 2021 Oct 20.
4
Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.循环细胞外囊泡作为心血管疾病的生物标志物和药物递送载体
Biomolecules. 2021 Mar 5;11(3):388. doi: 10.3390/biom11030388.
5
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.细胞外囊泡与心血管疾病:从病理生理学到诊断与治疗。
Cytokine Growth Factor Rev. 2023 Dec;74:40-55. doi: 10.1016/j.cytogfr.2023.09.006. Epub 2023 Sep 28.
6
Cardioprotective role of extracellular vesicles: A highlight on exosome beneficial effects in cardiovascular diseases.细胞外囊泡的心脏保护作用:外泌体对心血管疾病有益作用的重点介绍。
J Cell Physiol. 2019 Dec;234(12):21732-21745. doi: 10.1002/jcp.28894. Epub 2019 May 29.
7
Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors.细胞外囊泡与心血管系统:生物标志物和心脏保护效应因子。
Vascul Pharmacol. 2020 Dec;135:106790. doi: 10.1016/j.vph.2020.106790. Epub 2020 Aug 28.
8
Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.方法学在心血管研究中外泌体的鉴定和特征分析:从外泌体到微囊泡。
Cardiovasc Res. 2023 Mar 17;119(1):45-63. doi: 10.1093/cvr/cvac031.
9
Extracellular vesicles- crucial players in human pregnancy.细胞外囊泡——人类妊娠中的关键角色。
Placenta. 2023 Sep 7;140:30-38. doi: 10.1016/j.placenta.2023.07.006. Epub 2023 Jul 26.
10
Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.代谢物作为健康、癌症、胸腔积液和心血管疾病中细胞外囊泡的货物:一个用于诊断和治疗目的的新兴研究领域。
Biomed Pharmacother. 2023 Jan;157:114046. doi: 10.1016/j.biopha.2022.114046. Epub 2022 Dec 2.

引用本文的文献

1
Platelet-derived microparticles increase the interaction of colorectal cancer cells with the endothelium to promote metastatic events.血小板衍生微粒增加结肠癌细胞与内皮细胞的相互作用,以促进转移事件。
J Transl Med. 2025 Jul 25;23(1):843. doi: 10.1186/s12967-025-06858-9.

本文引用的文献

1
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial.同种异体人脂肪间充质基质细胞衍生外泌体治疗轻至中度阿尔茨海默病患者的临床安全性和有效性:一项I/II期临床试验
Gen Psychiatr. 2023 Oct 11;36(5):e101143. doi: 10.1136/gpsych-2023-101143. eCollection 2023.
2
Brown Adipose Tissue and BMP3b Decrease Injury in Cardiac Ischemia-Reperfusion.棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤。
Circ Res. 2023 Aug 4;133(4):353-365. doi: 10.1161/CIRCRESAHA.122.322337. Epub 2023 Jul 18.
3
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.
异体血小板衍生细胞外囊泡作为延迟伤口愈合潜在治疗剂的首次人体临床试验。
J Extracell Vesicles. 2023 Jul;12(7):e12332. doi: 10.1002/jev2.12332.
4
Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.肿瘤来源的外泌体传递肿瘤抑制因子 miR-3591-3p,诱导 M2 巨噬细胞极化,促进神经胶质瘤进展。
Oncogene. 2022 Oct;41(41):4618-4632. doi: 10.1038/s41388-022-02457-w. Epub 2022 Sep 9.
5
In vivo tracking of [Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration.正电子发射断层扫描(PET)示踪[Zr]Zr 标记的工程细胞外囊泡在体内的示踪,揭示了给药途径的器官特异性分布。
Nucl Med Biol. 2022 Sep-Oct;112-113:20-30. doi: 10.1016/j.nucmedbio.2022.06.004. Epub 2022 Jun 22.
6
Engineered extracellular vesicles and their mimics in cardiovascular diseases.工程化细胞外囊泡及其在心血管疾病中的模拟物。
J Control Release. 2022 Jul;347:27-43. doi: 10.1016/j.jconrel.2022.04.046. Epub 2022 May 4.
7
Small Extracellular Vesicles From Brown Adipose Tissue Mediate Exercise Cardioprotection.来自棕色脂肪组织的小细胞外囊泡介导运动对心脏的保护作用。
Circ Res. 2022 May 13;130(10):1490-1506. doi: 10.1161/CIRCRESAHA.121.320458. Epub 2022 Apr 7.
8
Review on Strategies and Technologies for Exosome Isolation and Purification.外泌体分离与纯化的策略与技术综述
Front Bioeng Biotechnol. 2022 Jan 5;9:811971. doi: 10.3389/fbioe.2021.811971. eCollection 2021.
9
Ischemic Heart-Derived Small Extracellular Vesicles Impair Adipocyte Function.缺血性心脏来源的小细胞外囊泡损害脂肪细胞功能。
Circ Res. 2022 Jan 7;130(1):48-66. doi: 10.1161/CIRCRESAHA.121.320157. Epub 2021 Nov 12.
10
Extracellular vesicles in cardiovascular disease.细胞外囊泡与心血管疾病
Adv Clin Chem. 2021;103:47-95. doi: 10.1016/bs.acc.2020.08.006. Epub 2020 Oct 1.